Clinical trial
Colchicine After Electrocardioversion for Atrial Fibrillation - The COLECTRO-AF Trial
NCT05890664 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Colchicine After Electrocardioversion for Atrial Fibrillation - The COLECTRO-AF Trial
- Lead sponsor
- University Hospital, Basel, Switzerland
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- April 14, 2024
- Completion date
- March 31, 2027
- Enrollment
- 416 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, cardiac arrhythmia